OBJECTIVE: Patients visiting the emergency department (ED) after a suicide attempt are generally assessed for suicide risk by psychiatric residents. Psychiatric residents' competence in evaluating the risk posed by the patients who attempted suicide is critical to preventing suicide. METHODS: We investigated factors considered important by psychiatric residents when evaluating suicide risk. This study included 140 patients admitted to the ED after attempting suicide. Psychiatric residents rated patients' severity of current and future suicide risk as low/moderate/high using the Brief Emergency Room Suicide Risk Assessment (BESRA). The association between each BESRA variable and level of suicide risk was analyzed. RESULTS: Many factors were commonly considered important in evaluating the severity of current and future suicide risk. However, the following factors were only associated with future suicide risk: female gender, having no religion, family psychiatric history, history of axis I disorders, having a will, harboring no regrets, and social isolation. CONCLUSION: Psychiatric residents use diverse factors when assessing suicide risk. Psychiatric residents might put more emphasis on non-modifiable demographic and clinical factors, concrete evidence showing suicide determination, and social isolation to assess the risk of future suicide.
Axis, Cervical Vertebra ; Emergency Service, Hospital ; Female ; Humans ; Mental Competency ; Risk Assessment* ; Risk Factors* ; Social Isolation ; Suicide* ; Suicide, Attempted

Overactive bladder (OAB) is defined as urgency, usually with frequency and nocturia, and with or without urge incontinence. Duloxetine, an antidepressant that inhibits reuptake of serotonin and norepinephrine, is indicated for the treatment of stress urinary incontinence in Europe. In this paper, we present a case of a 17-year-old female patient with OAB and depressive symptoms who was successfully treated with duloxetine. This case suggests duloxetine can be an option for patient with OAB, and it also highlights the need for further studies of duloxetine's use in the treatment of OAB.
Adolescent* ; Depression ; Europe ; Female* ; Humans ; Nocturia ; Norepinephrine ; Serotonin ; Urinary Bladder, Overactive* ; Urinary Incontinence ; Urinary Incontinence, Urge ; Duloxetine Hydrochloride

Many studies have reported spontaneous spinal epidural hematoma (SSEH). Although most cases are idiopathic, several are associated with thrombolytic therapy or anticoagulants. We report a case of SSEH coincident with acute myocardial infarction (AMI), which caused serious neurological deficits. A 56 year old man presented with chest pain accompanied with back and neck pain, which was regarded as an atypical symptom of AMI. He was treated with nitroglycerin, aspirin, low molecular weight heparin, and clopidogrel. A spinal magnetic resonance image taken after paraplegia developed 3 days after the initial symptoms revealed an epidural hematoma at the cervical and thoracolumbar spine. Despite emergent decompressive surgery, paraplegia has not improved 7 months after surgery. A SSEH should be considered when patients complain of abrupt, strong, and non-traumatic back and neck pain, particularly if they have no spinal pain history.
Anticoagulants ; Aspirin ; Chest Pain ; Hematoma ; Hematoma, Epidural, Spinal ; Heparin, Low-Molecular-Weight ; Humans ; Magnetic Resonance Spectroscopy ; Myocardial Infarction ; Neck Pain ; Nitroglycerin ; Paraplegia ; Spine ; Thrombolytic Therapy ; Ticlopidine

Phyllodes tumors of the breast are rare biphasic fibroepithelial neoplasms that may coexist with breast carcinomas. Herein, we report a case of invasive ductal carcinoma (IDC) within a borderline phyllodes tumor accompanied by extensive ductal carcinoma in situ (DCIS) in the same breast. A 72-year-old woman presented with a palpable lump in the right breast.Mammography showed an oval mass associated with segmental microcalcifications, and breast ultrasound (US) revealed a 2.3 cm oval mass and an associated non-mass lesion. Based on US-guided core needle biopsy, the initial biopsy result of the non-mass lesion suggested DCIS; however, the mass was diagnosed as a fibroepithelial lesion. Preoperative dynamic contrast-enhanced magnetic resonance imaging showed a rim-enhancing oval mass with areas of T2 hyperintensity, accompanied by segmental non-mass enhancement. The mass was highly suspicious for malignancy and was considered imaging-pathology discordant.Subsequently, the patient underwent mastectomy. Histopathological examination of the surgical specimens confirmed a borderline phyllodes tumor with an IDC within the tumor and an extensive intraductal component. The invasive carcinoma component was triplenegative breast cancer. This case highlights the diagnostic challenges of identifying coexisting carcinomas within phyllodes tumors and emphasizes the necessity for increased awareness among radiologists regarding this possibility.

Phyllodes tumors of the breast are rare biphasic fibroepithelial neoplasms that may coexist with breast carcinomas. Herein, we report a case of invasive ductal carcinoma (IDC) within a borderline phyllodes tumor accompanied by extensive ductal carcinoma in situ (DCIS) in the same breast. A 72-year-old woman presented with a palpable lump in the right breast.Mammography showed an oval mass associated with segmental microcalcifications, and breast ultrasound (US) revealed a 2.3 cm oval mass and an associated non-mass lesion. Based on US-guided core needle biopsy, the initial biopsy result of the non-mass lesion suggested DCIS; however, the mass was diagnosed as a fibroepithelial lesion. Preoperative dynamic contrast-enhanced magnetic resonance imaging showed a rim-enhancing oval mass with areas of T2 hyperintensity, accompanied by segmental non-mass enhancement. The mass was highly suspicious for malignancy and was considered imaging-pathology discordant.Subsequently, the patient underwent mastectomy. Histopathological examination of the surgical specimens confirmed a borderline phyllodes tumor with an IDC within the tumor and an extensive intraductal component. The invasive carcinoma component was triplenegative breast cancer. This case highlights the diagnostic challenges of identifying coexisting carcinomas within phyllodes tumors and emphasizes the necessity for increased awareness among radiologists regarding this possibility.

Phyllodes tumors of the breast are rare biphasic fibroepithelial neoplasms that may coexist with breast carcinomas. Herein, we report a case of invasive ductal carcinoma (IDC) within a borderline phyllodes tumor accompanied by extensive ductal carcinoma in situ (DCIS) in the same breast. A 72-year-old woman presented with a palpable lump in the right breast.Mammography showed an oval mass associated with segmental microcalcifications, and breast ultrasound (US) revealed a 2.3 cm oval mass and an associated non-mass lesion. Based on US-guided core needle biopsy, the initial biopsy result of the non-mass lesion suggested DCIS; however, the mass was diagnosed as a fibroepithelial lesion. Preoperative dynamic contrast-enhanced magnetic resonance imaging showed a rim-enhancing oval mass with areas of T2 hyperintensity, accompanied by segmental non-mass enhancement. The mass was highly suspicious for malignancy and was considered imaging-pathology discordant.Subsequently, the patient underwent mastectomy. Histopathological examination of the surgical specimens confirmed a borderline phyllodes tumor with an IDC within the tumor and an extensive intraductal component. The invasive carcinoma component was triplenegative breast cancer. This case highlights the diagnostic challenges of identifying coexisting carcinomas within phyllodes tumors and emphasizes the necessity for increased awareness among radiologists regarding this possibility.

Nicotinamide at millimolar concentrations affects cell survival in various conditions, and is being utilized therapeutically in many human diseases. However, the effect of an acute treatment of nicotinamide at such high dose on gene expression and cellular metabolism has rarely been determined previously. In this study, we found that levels of O-N-acetylglucosamin(O- GlcNAc)ylated proteins including Sp1 acutely decreased upon treatment of 10 mM nicotinamide. Concomitantly, Sp1 protein level decreased rapidly through accelerated proteasome-mediated proteolysis. Cotreatment of glucosamine or 2-deoxyglucose, which inhibits protein deGlcNAcylation, effectively blocked the decrease induced by nicotinamide. Interestingly, the decline in the levels of Sp1 and protein O- GlcNAcylation was only transient lasting for two days post treatment, and this pattern matched closely the rapid fluctuation of the cellular [NAD(+)]. Our results suggest a possible link between cellular nicotinamide metabolism and protein O-GlcNAcylation, and an existence of cellular [NAD(+)] homeostasis.
Acetylglucosamine/*metabolism ; Blotting, Western ; Dose-Response Relationship, Drug ; Down-Regulation/*drug effects ; Humans ; Hydrolysis ; Niacinamide/*pharmacology ; Reverse Transcriptase Polymerase Chain Reaction ; Sp1 Transcription Factor/metabolism

The present study aimed to examine the psychometric properties of the Korean version of Stanford Acute Stress Reaction Questionnaire (SASRQ). A Korean version of the SASRQ was produced through forward translation, reconciliation, and back translation. A total of 100 healthy, non-clinical participants were selected through screening and clinical interview, and they each were given a set of questionnaires including SASRQ. Psychometric properties of SASRQ were then examined through statistical analyses. Full-scale and subscales of SASRQ yielded excellent internal consistency (Cronbach's alpha=0.98 and 0.78-0.95, respectively). Test-retest reliability at 2-week intervals was satisfactory, with coefficient r ranging between 0.47 and 0.71. Convergent validity was also demonstrated by strong correlations between SASRQ and other trauma-related questionnaires. Correlation with Social Desirability Scale, however, was not found to be significant; thus evidenced divergent validity. The Korean version of SASRQ appears to be a reliable and valid measurement tool for assessing symptoms of acute stress disorder. Including clinical samples for comparison with controls would be necessary in future studies.
Adult ; Disability Evaluation ; Female ; Humans ; Male ; Psychometrics/*statistics & numerical data ; Questionnaires ; Reproducibility of Results ; Republic of Korea ; Stress Disorders, Post-Traumatic/*diagnosis ; Stress Disorders, Traumatic, Acute/*diagnosis

OBJECTIVES: The aim of this study was to investigate the effect of resilience on depression and life satisfaction in patients with end-stage renal disease (ESRD) on Hemodialysis. METHODS: Fifty ESRD patients, aged 18 or older, on hemodialysis visiting the hemodialysis room at Catholic University of Korea, Uijeongbu St. Mary's Hospital were included in this study. All patients were divided into two groups based on a Mini International Neuropsychiatric Interview : ESRD patients with major depressive disorder (MDD), and ESRD patients without MDD. The 17-item Hamilton Depression Rating Scale (HAM-D) and the Montgomery-Asberg Depression Rating Scale were used for assessment of the severity of depression symptoms. The Conner-Davidson Resilience Scale (CD-RISC) and Index of Well-being were used for measurement of resilience and life satisfaction, respectively. RESULTS: Sixteen (32%) patients were included in the MDD group, and 34 (68%) patients were included in the non-MDD group. The MDD group had significantly lower CD-RISC (p<0.005) and Index of well-being scores (p<0.005). The CD-RISC score showed a significant negative correlation with HAM-D-17 (r=-0.36, p<0.05) score and a positive correlation with Index of well-being score (r=0.37, p<0.01). Multiple regression analysis showed a significant relation of CD-RISC score with HAM-D-17 (beta=-0.36, p<0.05) and well-being score (beta=-0.56, p<0.005). CONCLUSION: Results of this study suggest that ESRD patients with higher resilience might be less depressed and have higher life satisfaction. Therefore, identification of clinical approaches that could increase resilience of ESRD patients might be important to prevention of depression and enhancement of life quality in ESRD patients on hemodialysis.
Aged ; Depression ; Depressive Disorder, Major ; Humans ; Kidney Failure, Chronic ; Korea ; Quality of Life ; Renal Dialysis

OBJECTIVE: Despite numerous atypical antipsychotics (AAP) available, many patients with schizophrenia still experience lack of efficacy and persistent side-effects. Switching from one AAP to another with a different side-effect profile has become a common clinical strategy. We aimed to investigate effect of switching to amisulpride in patients who showed suboptimal effect and/or tolerability to current antipsychotics treatment. METHODS: This was a 6-week, prospective, multicenter, open-label, flexible-dose study in patients with schizophrenia. Switching to amisulpride was achieved using cross-titration within 7 days (day 1: 300 mg on day 1 then flexibly dosed 400–800 mg/day). The primary end-point measure was proportion of patients achieving improvement in clinical benefit at week 6 based on Clinical Global Impressions-Clinical Benefit (CGI-CB). Secondary endpoints included change in scores in CGI-CB, CGI-Severity (CGI-S), Subjective Satisfaction Scores (SSS), Brief Psychiatric Rating Scale (BPRS), and Simpson and Angus Rating Scale. RESULTS: Among 37 patients switched to amisulpride, 76% completed study and 56.8% had clinical benefit measure by CGI-CB. CGI-CB and CGI-S scores showed significant improvement at week 6 compared to baseline (mean changes of CGI-CB and CGI-S scores: −1.7+1.0, p<0.0001 and −0.6±0.0, p=0.001, respectively). SSS scores also improved significantly (mean change: 2.1±2.6, p<0.0001). Mean weight of patients significantly lowered compared to baseline (mean change: −1.2±2.0, p<0.0001). CONCLUSION: Patients with schizophrenia who showed suboptimal efficacy or tolerability with their current antipsychotics and thereby switched to amisulpride resulted in clinical benefit in terms of both improved efficacy and tolerability. The small sample size limits generalizability of the study results.
Antipsychotic Agents* ; Brief Psychiatric Rating Scale ; Humans ; Prospective Studies ; Sample Size ; Schizophrenia